Affluent Medical SA (EPA: AFME)
France
· Delayed Price · Currency is EUR
1.665
0.00 (0.00%)
Nov 21, 2024, 10:31 AM CET
Affluent Medical Statistics
Total Valuation
Affluent Medical has a market cap or net worth of EUR 65.50 million. The enterprise value is 80.97 million.
Market Cap | 65.50M |
Enterprise Value | 80.97M |
Important Dates
The next estimated earnings date is Friday, December 27, 2024.
Earnings Date | Dec 27, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Affluent Medical has 39.34 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 39.34M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 1.42% |
Owned by Institutions (%) | 0.35% |
Float | 5.52M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -4.75 |
EV / Sales | 62.53 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -10.95 |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -38.05 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | 20,556 |
Profits Per Employee | -270,492 |
Employee Count | 63 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +34.92% in the last 52 weeks. The beta is 0.61, so Affluent Medical's price volatility has been lower than the market average.
Beta (5Y) | 0.61 |
52-Week Price Change | +34.92% |
50-Day Moving Average | 1.78 |
200-Day Moving Average | 1.76 |
Relative Strength Index (RSI) | 39.73 |
Average Volume (20 Days) | 1,958 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Affluent Medical had revenue of EUR 1.30 million and -17.04 million in losses.
Revenue | 1.30M |
Gross Profit | -1.01M |
Operating Income | -16.78M |
Pretax Income | -17.19M |
Net Income | -17.04M |
EBITDA | -14.73M |
EBIT | -16.78M |
Earnings Per Share (EPS) | n/a |
Balance Sheet
Cash & Cash Equivalents | n/a |
Total Debt | n/a |
Net Cash | n/a |
Net Cash Per Share | n/a |
Equity (Book Value) | n/a |
Book Value Per Share | n/a |
Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was -7.23 million and capital expenditures -171,000, giving a free cash flow of -7.40 million.
Operating Cash Flow | -7.23M |
Capital Expenditures | -171,000 |
Free Cash Flow | -7.40M |
FCF Per Share | -0.19 |
Margins
Gross Margin | -77.99% |
Operating Margin | -1,295.75% |
Pretax Margin | -1,327.41% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -571.12% |
Dividends & Yields
Affluent Medical does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | n/a |
FCF Yield | -11.29% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |